Envoy Medical, Inc.
COCH· Nasdaq
Filed Apr 3, 2023 · 10-K · 93 days after period end · 0001104659-23-040842
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|
| Net Income | -$11.48M | -$4.72M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Apr 3, 2023 · 93 d after period end